Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
However, the institution has simultaneously raised the target stock price from $100 to $115, demonstrating recognition of the company's long-term value. This rating adjustment reflects the analysts' balanced consideration between short-term risks and long-term potential. The upward revision of the target price may be based on ARCELLX's technological advancements in the CAR-T cell therapy field or positive signals from clinical trial data.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
The US dollar briefly pulled back to 157.0 against the Japanese yen, up 0.8% in the past 24 hours.
Odaily星球日报•2026/09/18 15:17
AutoZone Facing Near-Term Pressure From Recent Oil Price Spike, Oppenheimer Says
MT newswire•2026/09/18 15:14
Crypto prices
MoreBitcoin
BTC
$80,908.67
+6.16%
Ethereum
ETH
$2,579.68
+5.41%
Tether USDt
USDT
$0.9995
+0.03%
BNB
BNB
$756.26
+4.35%
XRP
XRP
$1.39
+6.91%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$109.78
+9.34%
TRON
TRX
$0.3390
+1.47%
Zcash
ZEC
$1,477.82
+3.72%
Hyperliquid
HYPE
$91.82
+12.58%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now